These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pulmonary hypertension-"state of the art" management in 2012. Saxena A Indian Heart J; 2012; 64(1):60-73. PubMed ID: 22572428 [TBL] [Abstract][Full Text] [Related]
10. Therapies for pulmonary arterial hypertension: where are we today, where do we go tomorrow? Seferian A; Simonneau G Eur Respir Rev; 2013 Sep; 22(129):217-26. PubMed ID: 23997048 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary arterial hypertension: the burden of disease and impact on quality of life. Delcroix M; Howard L Eur Respir Rev; 2015 Dec; 24(138):621-9. PubMed ID: 26621976 [TBL] [Abstract][Full Text] [Related]
12. Pulmonary hypertension in 2012: contemporary issues in diagnosis and management. Lau EM; Corte TJ Panminerva Med; 2012 Mar; 54(1):11-28. PubMed ID: 22278113 [TBL] [Abstract][Full Text] [Related]
13. Precision medicine and personalising therapy in pulmonary hypertension: seeing the light from the dawn of a new era. Savale L; Guignabert C; Weatherald J; Humbert M Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29653948 [TBL] [Abstract][Full Text] [Related]
14. Macitentan for the treatment of pulmonary arterial hypertension. Spikes L; Williamson T; Satterwhite L Drugs Today (Barc); 2014 Jun; 50(6):401-6. PubMed ID: 24983588 [TBL] [Abstract][Full Text] [Related]
15. Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension. Kylhammar D; Persson L; Hesselstrand R; Rådegran G Scand Cardiovasc J; 2014 Aug; 48(4):223-33. PubMed ID: 24912571 [TBL] [Abstract][Full Text] [Related]
16. Tadalafil as monotherapy and in combination regimens for the treatment of pulmonary arterial hypertension. Udeoji DU; Schwarz ER Ther Adv Respir Dis; 2013 Feb; 7(1):39-49. PubMed ID: 23129569 [TBL] [Abstract][Full Text] [Related]
17. Outcome of adults with Eisenmenger syndrome treated with drugs specific to pulmonary arterial hypertension: A French multicentre study. Hascoet S; Fournier E; Jaïs X; Le Gloan L; Dauphin C; Houeijeh A; Godart F; Iriart X; Richard A; Radojevic J; Amedro P; Bosser G; Souletie N; Bernard Y; Moceri P; Bouvaist H; Mauran P; Barre E; Basquin A; Karsenty C; Bonnet D; Iserin L; Sitbon O; Petit J; Fadel E; Humbert M; Ladouceur M Arch Cardiovasc Dis; 2017 May; 110(5):303-316. PubMed ID: 28286190 [TBL] [Abstract][Full Text] [Related]
19. Pathobiology of pulmonary arterial hypertension: understanding the roads less travelled. Hemnes AR; Humbert M Eur Respir Rev; 2017 Dec; 26(146):. PubMed ID: 29263173 [TBL] [Abstract][Full Text] [Related]
20. Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: where do we stand? Correale M; Ferraretti A; Monaco I; Grazioli D; Di Biase M; Brunetti ND Vasc Health Risk Manag; 2018; 14():253-264. PubMed ID: 30323613 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]